Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
The genetic underpinnings of Alzheimer's disease (AD) remain largely elusive despite early successes in identifying three genes that cause early-onset familial AD (those that encode amyloid precursor protein (APP) and the presenilins (PSEN1 and PSEN2)), and one genetic risk factor for late-onset AD (the gene that encodes apolipoprotein E (APOE)). A large number of studies that aimed to help uncover the remaining disease-related loci have been published in recent decades, collectively proposing or refuting the involvement of over 500 different gene candidates. Systematic meta-analyses of these studies currently highlight more than 20 loci that have modest but significant effects on AD risk. This Review discusses the putative pathogenetic roles and common biochemical pathways of some of the most genetically and biologically compelling of these potential AD risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ε4 allele of the apolipoprotein E (APOE) gene is the major genetic risk factor for AD and dementia with Lewy bodies (DLB) (1, 5, 6), whereas APOE2, a well-established longevity determinant, affords protection against the disease (7, 8).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [1]
In the citing paper
“Familial Alzheimer’s disease, which has an autosomal dominant form of inheritance and early onset, has been associated with mutations in APP, PSEN1 and PSEN2, three genes that are critical for beta amyloid (Aβ) production61.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [61]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citationAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citationTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1×
“Despite the lack of MAPT mutations in AD, it is likely that tau dysfunction still contributes to AD ris”
BackgroundRogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“, none of these candidates has been proved to consistently influence disease risk or onset age in more than a handful of sample”
BackgroundSelf-citation
Research works printed but not linked: 1
- Meyer, J. M. & Breitner, J. C. Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. Am. J. Med. Genet. 81, 92–97 (1998). · DOI · Paper page
Cited by
Items 601–700 of 754
Timsina, J., Jiang, C., McCartney, D. L., Tao, F., Dalmasso, M. C., Najar, J., Anastasi, F., Ohlei, O., Puerta, R., Yang, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71682-8 · Cited by 7
“We identi fi ed seven genome-wide signi fi cant loci for A β 42, nine for t-tau and eight for p-tau181 after combining results from both MTAG and pleioFDR (Supplementary Data 3, Supplementary Fig.”
Ashrafuzzaman, M., & Tuszyński, J. A. (2012) · Biological and medical physics series · doi:10.1007/978-3-642-16105-6_7 · Cited by 2
Assessment of Alzheimer’s Disease
Loewenstein, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3106-0_18 · Cited by 5
Paradigms lost: rethinking psychiatry in the postgenome era
McInnis, M. G. (2009) · Depression and Anxiety · doi:10.1002/da.20562 · Cited by 2
“2, have been reported.([9]) Many are within biochemical pathways involved in the metabolism of the amyloid b protein, the principal component of the hallmark senile plaques of AD.”
BackgroundSelenium in Alzheimer’s Disease
Bellinger, F. P., & Weeber, E. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1025-6_34 · Cited by 3
Amyloid imaging for Alzheimer's disease
Kerchner, G. A. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.617365 · Cited by 2
Etnier, J. L. (2014) · Kinesiology Review · doi:10.1123/kr.2014-0050 · Cited by 2
Role of the Proteasome in Fly Models of Neurodegeneration
Yeh, C.-H., Jansen, M., & Schmidt‐Glenewinkel, T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-328-8_10 · Cited by 3
NEUROLOGIC DISEASE AND ANESTHESIA
Culley, D. J., Brooks, M., & Crosby, G. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05908-4.10026-0 · Cited by 4
Driver or Passenger: Epigenomes in Alzheimer’s Disease
Hoffmann, A., Sportelli, V., Ziller, M. J., & Spengler, D. (2017) · Epigenomes · doi:10.3390/epigenomes1010005 · Cited by 2
“Causal, rare autosomal dominant mutations in the amyloid beta precursor protein (APP), and presilin 1 (PSEN1), and 2 (PSEN2) lead to early-onset familial Alzheimer’s disease [27], in support of the amyloid cascade hypothesis [12].”
BackgroundThyroid Hormone Enhances Neurite Outgrowth in Neuroscreen 1 Cells
Oldham, C. E., Wooten, C. J., & Lopez, D. (2018) · International Journal of Biomedical Investigation · doi:10.31531/2581-4745.1000104 · Cited by 3
“Risk factors described for AD include aging, familial aggregation for AD, familial aggregation for Down’s syndrome and Parkinson’s disease, late maternal age, head trauma, history of depression, diabetes mellitus, hypertension, obesity, smoking, cognitive or physical inactivity, and history of hypothyroidism [12-17].”
BackgroundExtracellular RNA in Alzheimer’s disease
Hicks, D. A. (2021) · ExRNA · doi:10.21037/exrna-21-2 · Cited by 1
“These differences in pathology are accompanied by vast genetic differences (206).”
BackgroundAssessment of Alzheimer’s Disease
Curiel, R. E., Raffo, A., & Loewenstein, D. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_29 · Cited by 3
王, 明., 李, 骜., 邹, 亮., & 黄, 琼. (2012) · Scientia Sinica Vitae · doi:10.1360/zc2012-42-8-639 · Cited by 2
Laborchemische Diagnostik und therapeutisches Drugmonitoring
Bondy, B., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-540-33129-2_23 · Cited by 2
Synthesis and Molecular Docking of New 1,2,3-triazole Carbohydrates with COVID-19 Proteins
Hamadi, N. B., Guesmi, A., Algathami, F. K., Khezami, L., Nouira, W., & El‐Fattah, W. A. (2022) · Current Organic Synthesis · doi:10.2174/1570179419666220414095602 · Cited by 2
Do amyloid-lowering strategies work clinically?
van Marum, R. J. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608101376 · Cited by 2
Genetic Studies of Alzheimer's Disease
Blom, E. S. (2008) · Uppsala University Publications (Uppsala University) · Cited by 2
Zeng, J., Gao, Z., Xiong, X., Hou, X., Qin, H., Liu, Y., Bowman, H., Ritchie, C. W., O'Brien, J. T., & Su, L. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241299124 · Cited by 1
Nabi, S. U., Rasool, I., Khan, A., Haq, A. U., Hussain, I., Khan, M. S., Majid, S., Rashid, S., Rashid, S. M., Sehar, N., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-025-01781-w · Cited by 1
Disease-associated RNA and protein signatures in iPSC-derived microglia model of Alzheimer’s disease
Wu, W., Choi, E. S., Liu, L., Thamilselvan, V., LI, L., Rippee‐Brooks, M. D., Khatkar, K., Li, D.-Y., McGrath, D., Manning, A. C., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1799542 · Cited by 1
“Despite extensive eorts to identify genetic and environmental risk factors and to elucidate the molecular mechanisms underlying disease onset and progression (Bertram and Tanzi, 2008; Kikuchi and Nakaya, 2019; Raulin et al., 2022; Stepler et al., 2022), there is currently no cure for AD.”
Wessinger, C. M., Park, K. S., DuBois, S. L., Wideman, L., Armstrong, B. D., Vance, J. C., Kibildis, S. W., Som‐Pimpong, H., & Etnier, J. L. (2026) · Journal of Nutritional Science · doi:10.1017/jns.2026.10106 · Cited by 1
RNA Pathologies in Neurological Disorders
Ohno, K., & Masuda, A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_14 · Cited by 1
Online-Datenbanken und systematische Metaanalysen komplex-genetischer Erkrankungen
Lill, C. M., & Bertram, L. (2010) · Medizinische Genetik · doi:10.1007/s11825-010-0225-0 · Cited by 1
Self-citationAutophagy-Derived Alzheimer’s Pathogenesis
Ling, D., & Paul, M. (2011) · InTech eBooks · doi:10.5772/17681 · Cited by 2
“Familial history as a risk factor is particularly associated with early-onset familial AD and is attributable to various inheritance-acquired mutations predominantly located in three genes: APP, PSEN1 and PSEN2 (Bertram & Tanzi, 2008).”
InfluentialChen, L. H., Kao, P. Y. P., Fan, Y., Ho, D. T. Y., Chan, S. Y., Yik, P. Y., Ha, J. C. T., Chu, L., & Song, Y. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.498 · Cited by 1
F4‐01‐02: Alzheimer's disease genetics: Current status and future perspectives
Bertram, L. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.507 · Cited by 1
“, 1993) none of these candidates has been proved to consistently influence disease risk or onset age in more than a handful of samples (Bertram and Tanzi, 2008).”
Self-citationFung, W. L. A., Naylor, M., Bennett, D. A. A., Lange, C., & Blacker, D. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32151 · Cited by 1
Measurement of beta-amyloid peptides in specific cells using a photo thin-film transistor
Kim, C.-B., Chae, C.-J., Shin, H., & Song, K. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-72 · Cited by 1
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
Adult Neurogenesis in Alzheimer’s Disease and Therapies
Taupin, P. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-940-2_18 · Cited by 3
“of the apolipoprotein E varepsilon 4 allele (ApoE4), hypertension, diabetes, and oxidative stress [17–20].”
BackgroundGenetic Variations: Heroes or Villains
Kaushik, M., Chaudhary, S., & Mahendru, S. (2016) · Journal of Down Syndrome & Chromosome Abnormalities · doi:10.4172/2472-1115.1000113 · Cited by 1
“These changes alter the structure and function of APOE gene and regulate its ability to bind lipids, receptors and amyloid-β, whose instability in the brain causes neurodegeneration and dementia [11].”
BackgroundPharmacogenomics and Personalized Medicine in Alzheimer’s Disease
Archer, T., & Johansson, B. E. A. (2013) · Springer eBooks · doi:10.1007/978-81-322-1184-6_15 · Cited by 1
Significant downregulation of Alzheimer's amyloid-β levels enabled by engineered DNA nanomaterials
Sun, Y., Sun, J. W., Feng, Y., Zhang, Y., Li, J., Wang, F., Loznik, M., Tian, Y., Zhang, H., Herrmann, A. P., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.03.017 · Cited by 2
Metallic Mysteries: Deciphering Their Contribution to Alzheimer’s Pathogenesis
Kalwaghe, S., Sadar, S., Porwal, P., Daswadkar, S. C., & Vyawahare, N. (2024) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2024.160323
Deep Learning-Based Classification of Alzheimer’s Disease from 2D Brain MRI
Meesala, S. S. D. P., Anuradha, T., Repakula, R. K., & Shaik, A. B. (2024) · International Conference on Smart Systems for Applications in Electrical Sciences (ICSSES) · doi:10.1109/icsses62373.2024.10561356 · Cited by 1
“Variations in genetic codes, including APP, PSEN1, and PSEN2, are linked to Alzheimer's, indicating that familial factors are likely to have a crucial part [6].”
BackgroundAlzheimer’s Disease: What Do We Know About It and How Can We Tackle It?
Mirpuri, B. (2022) · International journal of high school research · doi:10.36838/v4i2.13
Beneficial Effects of Citrus Flavonoids Against Aβ Pathology in Alzheimer’s Disease
Javed, H., Ojha, S. K., & Jamali, M. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_19 · Cited by 1
Les marqueurs biologiques de la maladie d'Alzheimer : quel intérêt pour un diagnostic moins tardif ?
Schraen‐Maschke, S., Dhaenens, C., Bombois, S., Deramecourt, V., Brussel, E. V., Obriot, H., Marzys, C., Sergeant, N., Maurage, C., Pasquier, F., et al. (2009) · Cited by 1
Marioni, R. E. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Lemke, H. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5253 · Cited by 1
Alzheimer's disease: a light at the end of the tunnel?
Robichaud, A. J., & Rotella, D. P. (2009) · Drug Development Research · doi:10.1002/ddr.20286 · Cited by 1
“This is based on experiments that demonstrated cytotoxicity when neurons were exposed to the peptide [Yankner, 1996] and on genetic studies that have associated increased Ab production with an increased risk of the development of AD [Bertram and Tanzi, 2008].”
Beaton, D., Rieck, J. R., Alhazmi, F. H., ADNI, & Abdi, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235945 · Cited by 1
Alzheimer's Disease and Other Dementias
McCracken, S. G. (2012) · Oxford University Press eBooks · doi:10.1093/obo/9780195389678-0115 · Cited by 1
Wu, Q., & Luo, X. (2019) · arXiv (Cornell University) · Cited by 1
Pink, D., Ilkel, E., Chandreswaran, V., Moser, D., Getzmann, S., Gajewski, P. D., Axmacher, N., & Zhang, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.11.556925 · Cited by 3
Bosch, M. E., Dodiya, H. B., Michalkiewicz, J., Lee, C., Shaik, S. M., Weigle, I. Q., Zhang, C. M., Osborn, J., Nambiar, A., Patel, P. A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3394003/v1 · Cited by 1
Self-citationTutrow, K. D., Harkin, J., Varghese, L., Hernandez, M., Huang, K.-C., Fang, Y., Wilcox, P., Bedford, L., Lin, T.-Y., Zhang, C., et al. (2025) · doi:10.1101/2025.07.01.662163 · Cited by 1
“Genetic variants expressed in microglia also influence susceptibility to neurodegenerative diseases (Andrews et al., 2020; Bertram and Tanzi, 2008; McQuade et al., 2020; Tsai et al., 2023).”
Noncoding RNAs in the Development, Function and Pathologies of the Central Nervous System
Szymański, M., & Barciszewski, J. (2009) · Springer eBooks · doi:10.1007/978-3-642-00475-9_20
“This process results from deregulation of the proteolytic cleavage of the amyloid precursor protein (APP) and may be due to mutations within presenilin (PSEN1 and PSEN2) genes encoding components of the proteolytic complex ( Bertram and Tanzi 2008 ), point mutations or duplication of APP gene that result in increased…”
BackgroundNeuroligins and Neurexins in Alzheimer’s disease
Sindi, I. A. (2014) · The University of Queensland · doi:10.14264/uql.2015.176
Genetic regulation of neuroinflammation: a translational approach
Öckinger, J. (2009) · Figshare
DFP: Therapie der Alzheimer-Demenz: Status quo und Zukunftsperspektiven
Moser, U., Kaser, S., & Winkler, D. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Cuál es el mejor modelo de estudio de la enfermedad de Azheimer
Aranda-Abreu, G. E., Hernández‐Aguilar, M. E., & García, L. I. (2010) · eNeurobiología
Animal Models of Neurodegenerative Diseases
Ghorayeb, I., Page, G., Gaillard, A., & Jaber, M. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_3 · Cited by 3
“It is actually considered that the genetic risk factor that accounts for more cases of AD than any other is the ApoE4 allele located on chromosome 19 (Bertram and Tanzi 2008).”
Castro, A. S. (2011) · Gredos (University of Salamanca) · doi:10.14201/gredos.110826
Stimulating Neuroprotective and Regenerative Mechanisms in Alzheimer Disease
Lilja, A. M. (2013) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8515 · Cited by 1
“…AD: APP on chromosome 21, including the Swedish double mutation 670/671, and the genes encoding the two presenilin (PS) proteins that are components of the γ-secretase complex, PSEN1 on chromosome 14 and PSEN2 on chromosome 1 (Bertram and Tanzi, 2008; Mullan et al., 1992; St George-Hyslop, 2000).”
BackgroundTamashiro-Duran, J. H. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-03012012-094605
First Full Genome Study Flags Four New Genetic Suspects in Late Alzheimer Disease
Samson, K. (2008) · Neurology Today · doi:10.1097/01.nt.0000342770.22059.aa
Is AD a homogeneous nosologic entity? Yes
Martínez‐Martín, P. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1059-0
“Hundreds of gene candidates are being investigated, although probably only a relative reduced number of loci will finally influence the risk for AD (Bertram and Tanzi 2008; Bettens et al. 2010).”
Chen, R., Hu, B.-Q., Zhang, D.-X., Zhang, Q., & Pang, C.-Y. (2012) · IEEE International Conference on Granular Computing (GrC) · doi:10.1109/grc.2012.6468605
The strong correlation of gene expression data on Alzheimer's disease and co-regulation of gene
Pang, C.-Y., Zhang, D.-X., Yang, L., Xia, X.-P., & Hu, B.-Q. (2011) · IEEE International Conference on Granular Computing (GrC) · doi:10.1109/grc.2011.6122713
“In last 30 years, research indicates that Alzheimer’s disease is associated with amyloid plaques and neurofibrillary tangles in the brain and several hypotheses exist trying to explain the cause of the disease [4].”
BackgroundPang, C.-Y., Li, Y., Liu, S.-Q., & Hu, B.-Q. (2011) · IEEE International Conference on Granular Computing (GrC) · doi:10.1109/grc.2011.6122714
Tarantello, C. (2009) · UPT. Syiah Kuala University Library (Syiah Kuala University)
What is the role of neuroimaging in dementia? A review
Narayanan, L., & Murray, A. D. (2014) · Imaging · doi:10.1259/img.20120015
Genotypes-phenotype predictions in patients diagnosed with early onset Alzheimer.
Zafeiropoulou, D. (2014)
Génétique des formes autosomiques dominantes de maladie d’Alzheimer
Wallon, D., Campion, D., & Hannequin, D. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_9
O papel do aminoácido leucina na modulação da atividade do peptídeo beta amiloide em células SH-SY5Y
Lorenzeti, F. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.39.2014.tde-20022015-101423
Ocular biomarkers for early detection and monitoring of Alzheimer's disease
Frost, S. M. (2013) · UWA Profiles and Research Repository (UWA)
Regulation of the kinesin-3 motor, KIF1A, in a cellular model of Alzheimer’s disease
Akram, A. (2016) · Summit (Simon Fraser University)
Hackett, L. P. (2015) · ODU Digital Commons (Old Dominion University) · doi:10.25777/sxze-8j56
“Amyloid plaques are characterized by an accumulation of the amyloid-β peptide (Aβ) which is generated from the amyloid precursor protein (APP; Bertram & Tanzi, 2008).”
BackgroundInfluentialImaging mouse models of neurodegeneration using multi-parametric MRI
Holmes, H. (2015) · UCL Discovery (University College London)
Lee, Y. (2012) · Georgetown University-Graduate School of Arts & Sciences
Söderberg, K. (2016) · DiVA at Umeå University (Umeå University)
Aronsen, E. (2009) · Duo Research Archive (University of Oslo)
Price, D. L., Savonenko, A. V., Li, T., & Wong, P. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.009
“Personal Training”: Can Genes Guide Us?
Tsolaki, A. (2015) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-4666-8234-4.ch002 · Cited by 1
Chapter 17 Neurological Disorders
Trevathan, E. (2010) · American Public Health Association eBooks · doi:10.2105/9780875531922ch17
Calcineurin regulates APP metabolism: In vitro & In vivo studies
Utreja, S., & Lacovara, K. J. (2013) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-6997
Microglia and Complement in Alzheimer's Disease with Cerebral Amyloid Angiopathy
Zabel, M. K. (2013) · The Scholars Repository - LLU (Loma Linda University)
Strategic options for the Pharmaceutical Industry in times of Challenge and Change
Pachidou, F. (2014) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010278917
Trevathan, E. (2016) · American Public Health Association eBooks · doi:10.2105/9780875532783ch19
Jeppsson, F. (2016) · DiVA (Stockholm University)
The Search for Biomarkers in Alzheimer's Disease
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.107 · Cited by 3
Labormedizinische Diagnostik in der Psychiatrie
Schwarz, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_26 · Cited by 2
Is AD a homogeneous nosologic entity? Yes
Wien, S.-V. (2013)
Evolutionary and functional data power search for obsessive-compulsive disorder genesPreprint
Noh, H. J., Tang, R., Flannick, J. A., O’Dushlaine, C. T., Swofford, R., Howrigan, D. P., Genereux, D. P., Johnson, J., van Grootheest, G., Grünblatt, E., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/107193
“Cath [22], Guoping Feng [1,2], Elinor K.”
Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00001-x · Cited by 1
Cellular models of human brain disorders from skin to brain
Shahsavani, M. (2018) · Figshare
Investigating the molecular pharmacology of the short chain fatty acid receptor FFA2
Sergeev, E. (2018) · Enlighten: Theses (The University of Glasgow) · Cited by 2
Kogel, F. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6936
Aging, cognitive ability and the risk of dementia in the Helsinki Birth Cohort Study
Rantalainen, V. (2019) · Helda - University of Helsinki Institutional Repository · Cited by 1
Design, Synthesis and Evaluation of Covalent Inhibitors for Tissue Transglutaminase and Factor XIIIa
Akbar, A. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-23888
Insulin resistance, dementia, and depression
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00008-0
Epigenetic Modifications lead towards Neurodegeneration
Askari, A., Noushad, S., Ahmed, S., Mirza, F., & Aziz, S. A. (2020) · INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) · doi:10.29052/jehsr.v8.i2.2020.86-108
CERAMIDE-ENRICHED EXTRACELLULAR VESICLES
Elsherbini, A. M. (2020) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2020.474
“1 Introduction Aβ plaque deposits and tau neurofibrillary tangle formation are hallmarks of AD [222, 223].”
Background
Metadata
- Authors
- Bertram, L., & Tanzi, R. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Bertram, Lars
- Venue
- Nature Reviews Neuroscience
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 768-778
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2018342879
- Cited by
- 747
- References
- 113
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 25 · 2023: 21 · 2022: 33 · 2021: 26 · 2020: 29 · 2019: 34 · 2018: 41 · 2017: 46 · 2016: 37 · 2015: 41 · 2014: 46 · 2013: 59 · 2012: 62
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (5R01-AG23667, R01AG023667)
- National Institute of Mental Health (5R37MH60009, R37MH060009)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease genetics, genetic risk factors, candidate genes, meta-analysis, amyloid precursor protein, presenilin 1, presenilin 2, apolipoprotein E, early-onset familial Alzheimer's disease, late-onset Alzheimer's disease, disease pathology, metabolic pathways
- MeSH terms
- Alzheimer Disease, Animals, Apolipoproteins E, Brain Chemistry, Humans, Mutation, Risk Factors, Meta-Analysis as Topic, Amyloid beta-Protein Precursor, Genetic Predisposition to Disease, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.